Skip to main content

Fortrea Holdings Inc.

corporate_fare Company Profile

Fortrea Holdings Inc.

FTRE·NASDAQ·Industrial Applications And Services·CIK 0001965040

Fortrea Holdings Inc. is a global contract research organization (CRO) that provides solutions for developing biopharmaceutical products and medical devices. The company serves pharmaceutical, biotechnology, and medical device customers. Fortrea offers clinical trial management services from Phase I through IV, clinical pharmacology, and consulting services. With over 30 years of experience, Fortrea supports customers across more than 20 therapeutic areas using agile delivery models, including Full Service, Functional Service Provider (FSP), and Hybrid structures. The company has approximately 14,300 employees and operates in approximately 100 countries. Fortrea manages its business as one reporting segment: Clinical Services. Fortrea Holdings Inc. was formed on June 29, 2023, through a spin-off of the CRO business from Labcorp Holdings Inc., becoming a standalone, publicly traded company.

Fortrea Holdings Inc. (NASDAQ:FTRE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors FTRE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Fortrea Loses CAO as CFO Transition Terms Finalized — $1M Severance Package
  • Fortrea Appoints Jason Knoblauch as New CFO, Reaffirms 2026 Guidance
  • Fortrea Holdings Announces CFO Departure, Successor Named for July
  • Fortrea Holdings Reports Substantial Reduction in Q1 Net Loss and Improved Operating Cash Flow
  • Fortrea Reports Q1 Revenue of $636.5M, Adjusted EPS $0.16; Reaffirms Full-Year Guidance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.72B
Net Income
-$986.2M
Diluted EPS
-$10.81
Op. Cash Flow
$113.5M
Free Cash Flow
$88.3M
Operating Income
-$872.6M
Cash & Equivalents
$174.6M
Total Debt
$1.05B
Debt / Equity
1.87×
Net Margin
-36.2%
Shares Outstanding
93.1M sh
Source: 10-K · filed 2026-02-26 · accession 0001628280-26-012244
Browse all tickers starting with F →
$20.66 -0.04% today
52-week range · as of 2026-07-14 $4.46 – $20.66
Market cap
$1.96B
Volume
3.2M (2.2× avg)
3-mo avg 1.5M
Live data · 2026-07-29 10:31 UTC · Pre-market

show_chartPrice Chart

Loading chart...

feed FTRE - Latest Insights

FTRE
Jul 14, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Fortrea Loses CAO as CFO Transition Terms Finalized — $1M Severance Package
Price at Filing: $18.03
Real-time Price: $20.66 info
Change: +$2.63 (+15%) info
Market Cap: $1.958B info
Sentiment: Negative
View Wiseek Article
FTRE
Jun 26, 2026, 4:42 PM EDT
Filing Type: 8-K
Importance Score:
7
Fortrea Appoints Jason Knoblauch as New CFO, Reaffirms 2026 Guidance
Price at Filing: $17.65
Real-time Price: $20.66 info
Change: +$3.01 (+17%) info
Market Cap: $1.958B info
Sentiment: Neutral
View Wiseek Article
FTRE
Jun 26, 2026, 7:32 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Fortrea Holdings Announces CFO Departure, Successor Named for July
Price at Filing: $17.35
Real-time Price: $20.66 info
Change: +$3.31 (+19%) info
Market Cap: $1.958B info
Sentiment: Neutral
View Wiseek Article
FTRE
May 05, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Fortrea Holdings Reports Substantial Reduction in Q1 Net Loss and Improved Operating Cash Flow
Price at Filing: $14.08
Real-time Price: $20.66 info
Change: +$6.58 (+47%) info
Market Cap: $1.958B info
Sentiment: Positive
View Wiseek Article
FTRE
May 05, 2026, 6:13 AM EDT
Source: Wiseek News
Importance Score:
8
Fortrea Reports Q1 Revenue of $636.5M, Adjusted EPS $0.16; Reaffirms Full-Year Guidance
Price at Filing: $12.26
Real-time Price: $20.66 info
Change: +$8.40 (+69%) info
Market Cap: $1.958B info
Sentiment: Neutral
View Wiseek Article
FTRE
May 05, 2026, 6:12 AM EDT
Filing Type: 8-K
Importance Score:
8
Fortrea Reports Strong Q1 Adjusted Profitability, Affirms Full-Year Guidance with Robust Book-to-Bill
Price at Filing: $12.26
Real-time Price: $20.66 info
Change: +$8.40 (+69%) info
Market Cap: $1.958B info
Sentiment: Positive
View Wiseek Article
FTRE
Apr 27, 2026, 6:11 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Fortrea Schedules Annual Meeting, Details Executive Compensation and New Performance Share Program
Price at Filing: $9.81
Real-time Price: $20.66 info
Change: +$10.85 (+111%) info
Market Cap: $1.958B info
Sentiment: Neutral
View Wiseek Article
FTRE
Feb 26, 2026, 4:04 PM EST
Filing Type: 10-K
Importance Score:
9
Fortrea Reports $986M Net Loss for 2025 Driven by $798M Goodwill Impairment
Price at Filing: $10.80
Real-time Price: $20.66 info
Change: +$9.86 (+91%) info
Market Cap: $1.958B info
Sentiment: Negative
View Wiseek Article
FTRE
Feb 26, 2026, 6:05 AM EST
Filing Type: 8-K
Importance Score:
8
Fortrea Reports Significant Goodwill Impairment and Lower 2026 Revenue Guidance
Price at Filing: $9.90
Real-time Price: $20.66 info
Change: +$10.76 (+109%) info
Market Cap: $1.958B info
Sentiment: Negative
View Wiseek Article